Target intelligence / Profile preview

StAR-related lipid transfer protein 5 (STARD5)

Target
STARD5
Molecular classification
Lipid transfer protein, Cholesterol transporter, START (StAR-related lipid transfer) domain family
01

Overview

StAR-related lipid transfer protein 5 (STARD5) is a cytosolic lipid transfer protein, highly expressed in liver, kidney, and immune cells (notably Kupffer cells and macrophages), that binds and transports cholesterol and its derivatives (e.g., 25-hydroxycholesterol) between intracellular membranes, such as from the cytoplasm to the endoplasmic reticulum and Golgi apparatus. Structurally, it contains a START domain, which forms a hydrophobic cavity for binding sterol molecules. STARD5 is upregulated in response to endoplasmic reticulum (ER) stress and functions to maintain intracellular and plasma membrane cholesterol homeostasis. Knockout studies in mice show that loss of STARD5 results in reduced plasma membrane cholesterol, altered cholesterol efflux, accumulation of intracellular lipids in macrophages, and increased hepatic triglycerides and cholesterol content, suggesting a key role in non-vesicular sterol transport and cell membrane cholesterol regulation. Despite broad interest in cellular cholesterol trafficking and homeostasis, STARD5 is not at present a direct therapeutic target or established disease biomarker.

Other names
StAR-related lipid transfer domain containing 5STARD5StARD5MGC10327START domain-containing protein 5stAR-related lipid transfer protein 5START domain containing 5StAR-related lipid transfer (START) domain containing 5
02

Mechanism of action

Not applicable (no drugs or tool compounds known to target STARD5)

03

Biological functions

Cholesterol binding and transportIntracellular lipid traffickingMaintenance of cholesterol homeostasisResponse to endoplasmic reticulum (ER) stressRegulation of plasma membrane cholesterol content
04

Disease associations

Altered expression or function implicated in lipid metabolism disordersHepatic steatosis (fatty liver, in mice)Intracellular cholesterol accumulationPossible relevance to immune cell functionOther (not directly linked to cancer, cardiovascular, or neurodegenerative disease in available literature)
05

Safety considerations

None directly established. Lipid and cholesterol homeostasis disruption could be a theoretical concern in modulation, but this is not a known target of any therapeutic agents

Beyond the preview

Go deeper on StAR-related lipid transfer protein 5 (STARD5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on StAR-related lipid transfer protein 5 (STARD5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call